tiprankstipranks
Trending News
More News >
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market

Dermapharm Holding SE (DMP) Ratios

Compare
12 Followers

Dermapharm Holding SE Ratios

DE:DMP's free cash flow for Q3 2025 was €―. For the 2025 fiscal year, DE:DMP's free cash flow was decreased by € and operating cash flow was €―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.84 1.60 2.45 3.34 3.01
Quick Ratio
0.87 0.79 1.30 1.79 1.48
Cash Ratio
0.45 0.40 0.69 1.03 0.91
Solvency Ratio
0.13 0.10 0.27 0.29 0.15
Operating Cash Flow Ratio
0.60 0.56 1.32 1.61 0.99
Short-Term Operating Cash Flow Coverage
2.73 1.97 154.38 105.24 5.90
Net Current Asset Value
€ -867.47M€ -985.13M€ -346.40M€ -387.91M€ -499.76M
Leverage Ratios
Debt-to-Assets Ratio
0.47 0.50 0.37 0.41 0.50
Debt-to-Equity Ratio
1.66 2.00 0.97 1.17 1.88
Debt-to-Capital Ratio
0.62 0.67 0.49 0.54 0.65
Long-Term Debt-to-Capital Ratio
0.60 0.64 0.49 0.53 0.64
Financial Leverage Ratio
3.51 4.01 2.66 2.83 3.80
Debt Service Coverage Ratio
1.78 1.32 17.32 24.43 4.66
Interest Coverage Ratio
3.61 3.33 19.75 33.77 14.62
Debt to Market Cap
0.49 0.47 0.25 0.12 0.19
Interest Debt Per Share
19.97 21.09 9.82 10.94 11.44
Net Debt to EBITDA
2.76 3.47 1.11 1.17 2.61
Profitability Margins
Gross Profit Margin
65.67%63.34%64.49%65.83%58.39%
EBIT Margin
18.61%14.18%22.31%32.01%16.96%
EBITDA Margin
26.03%23.39%32.18%37.98%23.50%
Operating Profit Margin
18.55%16.11%23.78%31.65%17.24%
Pretax Profit Margin
13.90%9.34%21.11%31.07%15.78%
Net Profit Margin
9.11%5.49%13.10%22.23%10.81%
Continuous Operations Profit Margin
9.00%5.33%14.26%22.12%11.01%
Net Income Per EBT
65.55%58.84%62.06%71.54%68.51%
EBT Per EBIT
74.93%57.95%88.76%98.16%91.55%
Return on Assets (ROA)
5.02%2.89%9.50%14.90%7.01%
Return on Equity (ROE)
17.61%11.57%25.25%42.14%26.66%
Return on Capital Employed (ROCE)
12.30%10.36%20.39%23.85%12.54%
Return on Invested Capital (ROIC)
7.60%5.55%12.45%16.93%8.40%
Return on Tangible Assets
10.09%6.01%16.05%24.73%12.99%
Earnings Yield
5.38%2.74%6.65%4.36%2.80%
Efficiency Ratios
Receivables Turnover
10.01 11.90 10.60 13.00 14.30
Payables Turnover
4.01 4.80 6.49 6.18 6.56
Inventory Turnover
1.15 1.30 1.45 1.34 1.63
Fixed Asset Turnover
3.74 3.43 4.54 4.24 3.98
Asset Turnover
0.55 0.53 0.73 0.67 0.65
Working Capital Turnover Ratio
3.76 4.11 3.02 2.99 3.07
Cash Conversion Cycle
261.98 235.99 230.74 241.52 194.46
Days of Sales Outstanding
36.46 30.67 34.45 28.07 25.53
Days of Inventory Outstanding
316.55 281.31 252.55 272.47 224.59
Days of Payables Outstanding
91.03 75.98 56.26 59.02 55.65
Operating Cycle
353.01 311.98 287.00 300.54 250.11
Cash Flow Ratios
Operating Cash Flow Per Share
4.02 4.08 5.36 4.65 2.43
Free Cash Flow Per Share
3.27 3.30 4.63 3.51 1.68
CapEx Per Share
0.75 0.77 0.72 1.14 0.76
Free Cash Flow to Operating Cash Flow
0.81 0.81 0.86 0.76 0.69
Dividend Paid and CapEx Coverage Ratio
2.46 2.24 1.85 2.31 1.56
Capital Expenditure Coverage Ratio
5.37 5.28 7.40 4.09 3.21
Operating Cash Flow Coverage Ratio
0.21 0.20 0.56 0.43 0.22
Operating Cash Flow to Sales Ratio
0.18 0.19 0.28 0.27 0.17
Free Cash Flow Yield
8.75%7.80%12.35%3.93%2.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.62 36.55 15.05 22.94 35.73
Price-to-Sales (P/S) Ratio
1.70 2.01 1.97 5.10 3.86
Price-to-Book (P/B) Ratio
3.28 4.23 3.80 9.67 9.53
Price-to-Free Cash Flow (P/FCF) Ratio
11.44 12.82 8.10 25.42 33.96
Price-to-Operating Cash Flow Ratio
9.26 10.39 7.00 19.20 23.39
Price-to-Earnings Growth (PEG) Ratio
5.11 -0.68 -0.42 0.16 3.19
Price-to-Fair Value
3.28 4.23 3.80 9.67 9.53
Enterprise Value Multiple
9.31 12.06 7.24 14.60 19.04
Enterprise Value
2.85B 3.20B 2.39B 5.23B 3.55B
EV to EBITDA
9.30 12.06 7.24 14.60 19.04
EV to Sales
2.42 2.82 2.33 5.54 4.48
EV to Free Cash Flow
16.25 18.00 9.56 27.64 39.34
EV to Operating Cash Flow
13.22 14.59 8.27 20.88 27.10
Tangible Book Value Per Share
-8.74 -10.74 -0.81 -1.11 -4.44
Shareholders’ Equity Per Share
11.35 10.01 9.87 9.24 5.98
Tax and Other Ratios
Effective Tax Rate
0.35 0.43 0.39 0.29 0.31
Revenue Per Share
21.97 21.09 19.03 17.51 14.74
Net Income Per Share
2.00 1.16 2.49 3.89 1.59
Tax Burden
0.66 0.59 0.62 0.72 0.69
Interest Burden
0.75 0.66 0.95 0.97 0.93
Research & Development to Revenue
0.00 <0.01 0.01 0.02 0.02
SG&A to Revenue
0.00 0.02 0.02 0.01 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.32 3.52 1.33 0.85 1.05
Currency in EUR